Autolus Therapeutics plc - ADR

NASDAQ:AUTL   3:59:50 PM EDT
3.67
-0.09 (-2.39%)
Earnings Announcements

Autolus Therapeutics Reports Q2 2022 Financial Results

Published: 08/04/2022 11:43 GMT
Autolus Therapeutics plc - ADR (AUTL) - Autolus Therapeutics Reports Second Quarter 2022 Financial Results and Operational Progress.
Autolus Therapeutics Plc - Qtrly Loss per Share $0.46.
Revenue is expected to be $0.28 Million
Adjusted EPS is expected to be -$0.45

Next Quarter Revenue Guidance is expected to be $0.24 Million
Next Quarter EPS Guidance is expected to be -$0.46

More details on our Analysts Page.